Tumor-infiltrating lymphocytes glowing with tumor focused in the center

Welcome to the TIL Cell Therapy Working Group

The TlL Working Group is a team of internationally-recognized oncologists dedicated to helping healthcare practitioners better understand TIL cell therapy. TIL cell therapy is a type of cell therapy in which tumor-infiltrating lymphocytes are harvested from a patient’s tumor and grown in large numbers in vitro. These lymphocytes are then given back to the patient by infusion to help the immune system recognize and eliminate cancer cells.
Tumor-infiltrating lymphocytes glowing

TIL Cell Therapy Overview

TIL cell therapy is the autologous transfer of tumor-infiltrating lymphocytes obtained from a patient’s tumor. Learn more about the mechanism of action of TIL cell therapy and the components of this novel cell therapy.

Download TIL Cell Therapy Overview
Immunology Background
Immunology Background 2
Immunology Background 3
Immunology Background 4
Immunology Background 5
Immunology Background 6
Immunology Background 7
Immunology Background 8
Immunology Background 9
Immunology Background 10
Immunology Background 11
Immunology Background 12
Immunology Background 13
Immunology Background 14
Immunology Background 15
Immunology Background 16
Immunology Background 17
Immunology Background 18
Immunology Background 19
Previous slide
Next slide
Previous slide
Next slide
Previous slide
Next slide
Previous slide
Next slide
Previous slide
Next slide
Previous slide
Next slide

Tumor Resection

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Adipiscing neque, tristique donec ac leo vestibulum hendrerit ultricies eget. Facilisis hendrerit in interdum sit viverra. Sed in aliquet fames enim ac maecenas.
Up close surgeons' hands with instruments for tumor resection
Isolated tumor-infiltrating lymphocyte illustrative of TIL production

TIL Production

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Adipiscing neque, tristique donec ac leo vestibulum hendrerit ultricies eget. Facilisis hendrerit in interdum sit viverra. Sed in aliquet fames enim ac maecenas.

TIL Infusion

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Adipiscing neque, tristique donec ac leo vestibulum hendrerit ultricies eget. Facilisis hendrerit in interdum sit viverra. Sed in aliquet fames enim ac maecenas.
Tumor-infiltrating lymphocytes moving illustrative of TIL infusion
Female patient hooked up to IV infusion pump illustrative of lymphodepletion

Lymphodepletion

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Adipiscing neque, tristique donec ac leo vestibulum hendrerit ultricies eget. Facilisis hendrerit in interdum sit viverra. Sed in aliquet fames enim ac maecenas.

IL-2 Treatment

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Adipiscing neque, tristique donec ac leo vestibulum hendrerit ultricies eget. Facilisis hendrerit in interdum sit viverra. Sed in aliquet fames enim ac maecenas.
Small molecular size protein fields illustrative of IL-2 treatment

IL-2 Treatment

A short course of high-dose IL-2 is administered after TIL infusion to support T-cell activity. Learn more about best practices in IL-2 treatment as part of TIL cell therapy.
Small molecular size protein fields illustrative of IL-2 treatment
Download IL-2 Treatment Overview
IL2 4
IL2 5
IL2 6
IL2 7
IL2 8
Previous slide
Next slide
Previous slide
Next slide

Contact Us

For more information about TIL cell therapy or the TIL Working Group, contact us using the form below.



    © Copyright 2022 TIL Working Group   |  Privacy Policy